Compare RYAM & ANGO Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
| Metric | RYAM | ANGO |
|---|---|---|
| Founded | 1926 | 1988 |
| Country | United States | United States |
| Employees | 2325 | N/A |
| Industry | Paper | Medical/Dental Instruments |
| Sector | Basic Materials | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 491.8M | 462.0M |
| IPO Year | 2014 | 2004 |
| Metric | RYAM | ANGO |
|---|---|---|
| Price | $10.91 | $10.97 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 1 | 3 |
| Target Price | $14.00 | ★ $19.33 |
| AVG Volume (30 Days) | ★ 1.2M | 304.1K |
| Earning Date | 06-01-2026 | 01-01-0001 |
| Dividend Yield | N/A | N/A |
| EPS Growth | N/A | ★ 81.92 |
| EPS | N/A | ★ N/A |
| Revenue | ★ $1,466,397,000.00 | $291,010,000.00 |
| Revenue This Year | $5.46 | $9.11 |
| Revenue Next Year | $8.02 | $4.94 |
| P/E Ratio | N/A | ★ N/A |
| Revenue Growth | N/A | ★ 10.17 |
| 52 Week Low | $3.35 | $8.36 |
| 52 Week High | $11.17 | $13.99 |
| Indicator | RYAM | ANGO |
|---|---|---|
| Relative Strength Index (RSI) | 66.57 | 48.16 |
| Support Level | $7.09 | $10.37 |
| Resistance Level | N/A | $11.03 |
| Average True Range (ATR) | 0.74 | 0.34 |
| MACD | 0.18 | -0.04 |
| Stochastic Oscillator | 93.53 | 41.46 |
Rayonier Advanced Materials Inc is engaged in the production of cellulose specialties, a natural polymer used in the manufacturing of various specialty chemical products, including liquid crystal displays, filters, textiles and performance additives for pharmaceutical, food and other industrial applications. The company's products are used in a variety of applications, including cigarette filters, liquid crystal displays, paints, pharmaceuticals, and food. The company operates in the reportable segments of High Purity Cellulose, Paperboard, and High-Yield Pulp. The key revenue is derived from the High Purity Cellulose segment. Geographically, it derives a majority of its revenue from the United States.
AngioDynamics Inc designs manufactures, and sells medical, surgical, and diagnostic devices used by professional healthcare providers for the treatment of peripheral vascular disease and for use in oncology and surgical settings. Geographically, the company derives a majority of its revenue from the United States from sale of Med Tech and Med Device.